ARIZONA STATE UNIVERSITY
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.asu.edu
Clinical Trials
221
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (212 trials with phase data)• Click on a phase to view related trials
Sustainability Via Active Garden Education Wellness Implementation Strategies in Early Care and Education
- Conditions
- Implementation ScienceDiet, Food, and NutritionChild CareMotor Behavior
- First Posted Date
- 2025-11-14
- Last Posted Date
- 2025-11-17
- Lead Sponsor
- Arizona State University
- Target Recruit Count
- 871
- Registration Number
- NCT07228819
- Locations
- 🇺🇸
Arizona State University, Phoenix, Arizona, United States
Cognitive Vitality Pilot Study
- Conditions
- AgingHealthy AgingCognitionMemoryBrain
- First Posted Date
- 2025-10-06
- Last Posted Date
- 2025-10-28
- Lead Sponsor
- Arizona State University
- Target Recruit Count
- 16
- Registration Number
- NCT07208279
- Locations
- 🇺🇸
Community, West Palm Beach, Florida, United States
Adequate Hydration and Health Outcomes
- Conditions
- DehydrationDehydration (Physiology)Glucose AbnormalitiesCardiovascular
- First Posted Date
- 2025-09-17
- Last Posted Date
- 2025-09-17
- Lead Sponsor
- Arizona State University
- Target Recruit Count
- 144
- Registration Number
- NCT07179107
- Locations
- 🇺🇸
850 Phoenix Bioscience Core, Phoenix, Arizona, United States
Project Vuselela Feasibility
- Conditions
- HIVDrug Users
- First Posted Date
- 2025-08-12
- Last Posted Date
- 2025-08-12
- Lead Sponsor
- Arizona State University
- Target Recruit Count
- 80
- Registration Number
- NCT07117656
- Locations
- 🇿🇦
Anova Health Institute, Johannesburg, South Africa
Assessing the Feasibility of Coach Mpilo for Men With TB and HIV
- Conditions
- TuberculosisHIV
- First Posted Date
- 2025-08-12
- Last Posted Date
- 2025-08-12
- Lead Sponsor
- Arizona State University
- Target Recruit Count
- 240
- Registration Number
- NCT07117370
- Locations
- 🇿🇦
Desmond Tutu Health Foundation, East London, South Africa
- Prev
- 1
- 2
- 3
- 4
- 5
- 44
- Next
News
Skin Biopsy Test Detects Neurodegenerative Biomarker in 75% of REM Sleep Disorder Patients
The Syn-One Test successfully detected phosphorylated alpha-synuclein in skin biopsies of 75% of patients with idiopathic REM sleep behavior disorder, closely mirroring the 73.5% conversion rate to neurodegenerative diseases within 12 years.
Sidney Hecht Honored for Pioneering Work Linking Chemistry and Biology to Combat Disease
• Sidney Hecht received the Arizona Bioscience Pioneer Award for Lifetime Achievement for merging biology and chemistry to improve human health. • Hecht's research at ASU's Biodesign Center focuses on mitochondrial disorders, particularly Friedreich’s ataxia, a genetic neuromuscular disease. • Hecht played a key role in developing Hycamtin, a chemotherapy drug for ovarian and lung cancer, and studied the anti-tumor agent Bleomycin. • His center has developed compounds that redirect electrons in dysfunctional respiratory chains, with one in clinical trials for Friedreich’s ataxia.